Search

everythinglearnresearchcommunity

for

Search:↓

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Silastic-Dacron strips effectively prevent stretch-back after hair reduction surgeries.

Using tissue adhesive in hair transplants improves results and patient satisfaction, with fewer complications.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Melanin may help melanoma cells grow by aiding their metabolism.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Some blood thinners can cause hair loss, but switching medications can stop it.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.